Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles Moelis & Company (NYSE: MC) SEC filings, giving investors structured access to the firm’s regulatory disclosures as a global independent investment bank in the investment banking and securities dealing industry. Filings such as Form 8-K, Form 10-K, Form 10-Q, and Form 4 provide insight into Moelis & Company’s financial performance, governance, and insider activity.
Moelis & Company uses Current Reports on Form 8-K to announce material events, including quarterly financial results and board changes. For example, the company files 8-Ks when it releases earnings for specific quarters and when its Board elects a new independent director, detailing items such as results of operations, updated investor presentations, and director compensation arrangements.
Investors can look to the firm’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available on this page) for more comprehensive information on revenues, expenses, net income, segment drivers, and risk factors. Moelis & Company also discusses its use of Adjusted (non-GAAP) metrics in conjunction with GAAP results, and its filings reference the ownership structure of Moelis & Company Group LP and related tax treatment.
In addition, Form 4 insider transaction reports, when present, can help users track purchases, sales, and equity awards involving Moelis & Company’s directors and executive officers. Proxy-related filings may further describe board composition, director independence, and compensation practices, as illustrated by the firm’s disclosure of compensation for an independent director in a Form 8-K.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, explain complex sections in simpler language, and surface notable items such as changes in revenues, margins, dividends, or governance. With real-time updates from EDGAR and organized access to 10-Ks, 10-Qs, 8-Ks, and Form 4s, this page helps users quickly understand what Moelis & Company is reporting to regulators and how those disclosures relate to its advisory-focused business model.
Moelis & Company director reports dividend-equivalent RSUs
A Moelis & Company director filed a Form 4 reporting automatic grants of dividend-equivalent restricted stock units (RSUs) tied to earlier equity awards. On 12/04/2025, the director received 2,051.34 2024 Annual RSUs, 1,711.63 2025 Annual RSUs, and 1,406.17 2025 Elective RSUs. Each RSU represents the right to receive one share of Moelis Class A common stock.
The 2024 Annual RSUs were issued as dividend equivalents on Annual RSUs granted on July 1, 2024, while the 2025 Annual and 2025 Elective RSUs were issued as dividend equivalents on awards granted on July 1, 2025. All of these dividend-equivalent RSUs will vest on the same schedule as their respective underlying RSU awards.
Moelis & Company director Thorold Barker reported an acquisition of restricted stock units tied to the firm’s Class A common stock. The filing shows a grant of 2025 Annual Restricted Stock Units, which were issued as dividend equivalents on Barker’s existing Annual RSUs that were originally granted on July 14, 2025. Each RSU represents the right to receive one share of Class A common stock.
The dividend equivalent RSUs will vest at the same time and on the same schedule as the underlying Annual RSUs. Following this transaction, Barker is reported to beneficially own 1,630.18 shares of Moelis & Company Class A common stock directly, indicating his ongoing equity alignment with the company as a board member.
Moelis & Company executive Eric Cantor, a director and Vice Chairman/Managing Director, reported routine equity compensation activity in Class A common stock. On 12/05/2025, 668.41 shares were acquired following the exercise of restricted stock units and then an equal number of shares was disposed of at $66.45 per share, leaving 218,805 Class A shares held directly.
Related derivative entries show multiple grants of incentive and long-term incentive restricted stock units on 12/04/2025, all with a conversion price of $0, representing stock-based awards. The explanations state these RSUs were largely issued as dividend equivalents on previously granted unvested RSUs and will vest in line with those underlying awards. Certain RSUs and shares were settled or used specifically to satisfy tax obligations under the company’s retirement eligibility and tax policies.
Moelis & Company reported director equity awards tied to prior grants. Director Louise Mirrer filed a Form 4 for Restricted Stock Units (RSUs) in Moelis & Co Class A Common Stock as of 12/04/2025.
The filing shows several lines of 2024 and 2025 Annual RSUs that were acquired as dividend equivalents on her existing Annual RSU awards from September 2024, May 2025, and July 2025. Each RSU represents the right to receive one share of Class A Common Stock, and the dividend-equivalent RSUs will vest on the same schedule as the underlying Annual RSUs.
The form is filed for one reporting person, in her capacity as a director, and is signed by an attorney-in-fact on her behalf.
Moelis & Company reported an insider equity transaction for Principal Accounting Officer Nick Riehl. On 12/04/2025, Riehl received additional restricted stock units (RSUs) linked to the company’s Class A common stock, including 9.58, 2.41, and 3.21 RSUs tied to Class A shares at an exercise price of $0.
Each RSU represents the right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement. The new RSUs were issued as dividend equivalents on unvested incentive and long-term incentive RSUs that were originally granted on February 15, 2024 and February 13, 2025. These dividend equivalent RSUs will vest at the same time as the related unvested underlying RSUs.
Moelis & Company (MC) insider transaction: Executive Chairman and Director Kenneth Moelis reported an automatic conversion on 10/30/2025, resulting in the acquisition of 73 shares of Class A common stock (code M).
Following this transaction, he beneficially owns 209,310 shares of Class A common stock. The filing also shows 4,191,326 derivative securities (Class B common stock) beneficially owned after the reported transaction. Footnotes indicate the conversion occurred pursuant to the company’s charter when certain Group Units were exchanged by selling stockholders.
Moelis & Company reported stronger Q3 2025 results. Revenue rose to $356.9 million from $273.8 million a year ago, lifting operating income to $48.3 million from $15.6 million. Net income attributable to the company increased to $53.4 million versus $16.9 million, with diluted EPS of $0.67 compared to $0.22. Year to date, revenue reached $1,028.9 million versus $755.8 million, and diluted EPS was $1.84 versus $0.61.
Operating cash flow for the first nine months was $237.6 million, up from $112.1 million, driven by higher earnings. Cash and cash equivalents were $281.6 million as of September 30, 2025, while investments expanded to $366.8 million. The company realized a $19.1 million gain on a partial sale of its MA Financial stake in Q3 and received $2.3 million of dividends year to date. Moelis continued returning capital with quarterly dividends of $0.65 per Class A share and repurchased $28.5 million of shares year to date. Shares outstanding were 73,996,339 Class A and 4,324,418 Class B as of October 15, 2025.
Moelis & Company furnished an update on October 29, 2025. The company issued a press release announcing financial results for the third quarter ended September 30, 2025, and made an updated investor presentation available on its Investor Relations website.
The press release is attached as Exhibit 99.1 and, along with the presentation update, is furnished but not filed.
Nick Riehl, an officer and director at Moelis & Co (MC), reported receipt of restricted stock units (RSUs) on 09/18/2025. The Form 4 shows three grants labelled as 2023 Long Term Incentive RSUs, 2024 Incentive RSUs, and 2024 Long Term Incentive RSUs issued as dividend equivalents and recorded as acquisitions on that date. Each RSU represents the right to receive either a share of Class A common stock or cash equal to the share value upon settlement. The filing records beneficial ownership amounts of 979.01, 246.42, and 327.88 shares respectively after the transactions, with a reported price of $0 because these are dividend-equivalent RSUs that vest with the underlying awards.
Moelis & Co (MC) director Kenneth Shropshire reported receipt of restricted stock units on 09/18/2025. The Form 4 shows three dividend-equivalent RSU issuances tied to prior grants: 2024 Annual RSUs, 2025 Annual RSUs, and 2025 Elective RSUs. The filing lists numeric values associated with each line: 17.64 (2024 Annual), 14.72 (2025 Annual), and 1.74 (2025 Elective), and reports the amount of securities beneficially owned following the transactions as 2,127.9, 1,775.72, and 209.74 respectively. Shropshire is identified as a director and the Form 4 was signed by an attorney-in-fact, Osamu Watanabe, on 09/19/2025.